Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.
about
Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell linePlumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.Potential natural mTOR inhibitors screened by in silico approach and suppress hepatic stellate cells activation.
P2860
Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@ast
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@en
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@nl
type
label
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@ast
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@en
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@nl
prefLabel
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@ast
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@en
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@nl
P2093
P2860
P356
P1476
Withagulatin A inhibits hepati ...... t and Smad signaling pathways.
@en
P2093
P2860
P2888
P304
P356
10.1038/APS.2010.72
P50
P577
2010-07-19T00:00:00Z
P5875
P6179
1034216624